Mepha Pharma AG - Sitagliptin-Metformin-Mepha 50/850 mg, Filmtabletten | | 68378 | | 02 | | Sitagliptin-Metformin-Mepha 50/850 mg | | Filmtabletten | | A10BD07 | | Metformine et Sitagliptine | | 05.04.2022 | | |
| Composition | metformini hydrochloridum 850 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum K 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, glyceroli monocaprylocapras, poly(alcohol vinylicus), E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 1.74 mg. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Metformine Hydrochloride | 850 mg | Sitagliptine | 50 mg |
| BAG: Principe actif | Concentr. |
---|
Metformine Hydrochloride | 850 mg | Sitagliptine | 50 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Rubrum) | | | Cellulosum Microcristallinum | | | Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum | | Überzug | E 171 | | color. | E 172 | | color. | Glyceroli Monocaprylocapras | | | Natrii Laurilsulfas | | | Natrii Stearylis Fumaras | | | Poly(Alcohol Vinylicus) | | | Povidonum K | 29-32 | | Pro Compresso Obducto | | | Talcum | | |
| |
| |
|